Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Aug. 24, 2018. Thomas Wicks.

Executive Summary

FDAAA Trials Tracker, an online interactive tool, has found that only 747 of a possible 1,249 trials have reported results in compliance with the Food and Drug Administration Amendments Act of 2007 (FDAAA), and that the US government could impose more than $498m in fines – but thus far has not. See what Thomas Wicks, chief strategy officer for consulting firm TrialScope, said about the Trials Tracker data here.

"That's an effort to, perhaps, cajole, nudge or shame [these sponsors] and draw attention to the lack of enforcement." –Thomas Wicks, chief strategy officer, TrialScope

Click here for a free trial of Medtech Insight


Related Content

TrialScope Anticipates FDA Will Begin Inspecting Companies For Trial-Reporting Compliance





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts